Sign inJoin waitlistJoin the waitlist

Mehmet Ozkaynak

Director, Pediatric Solid Tumor Program · Westchester Medical Center

Credentials: · · · ·

History

New York Medical College · Westchester Medical Center
Present

Children’s Hospital of LA
1981–1982
Pediatrics
Children's Hospital Los Angeles
1978–1981
New York Medical College
1974–1978

Research

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
New England Journal of Medicine · 2010 · 1,404 citations
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032
Clinical Cancer Research · 2021 · 184 citations
Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma…
Journal of Clinical Oncology · 2000 · First of 9 authors · 148 citations

CS
Claudio Sandoval
31 papers
SJ
Somasundaram Jayabose
29 papers
Oya Tugal
18 papers
Alice Yu
9 papers
Paul Sondel
9 papers
AG
Andrew Gilman
7 papers
Julie Park
7 papers
Katherine Matthay
7 papers
John Maris
6 papers
Mitchell Cairo
6 papers
RS
Robert Seeger
6 papers
Gustavo Stringel
5 papers

Clinical trials

Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma
Principal investigator · Completed · Phase 3
National Cancer Institute (NCI)
2009–2021